Hoyne P A, Elleman T C, Adams T E, Richards K M, Ward C W
CSIRO Health Sciences and Nutrition, 343 Royal Parade, Parkville, Australia.
FEBS Lett. 2000 Mar 3;469(1):57-60. doi: 10.1016/s0014-5793(00)01237-0.
The insulin receptor (IR) and the insulin-like growth factor-I receptor (IGF-1R) show differential binding of insulin and IGFs. The specificity determinants for IGF-1 binding are known to be located in the cysteine-rich (Cys-rich) region between residues 223 and 274 of human IGF-1R, which includes a loop that protrudes into the putative ligand binding site. In this report we have replaced residues 260-277 of human IR with residues 253-266 of the human IGF-1R to produce an IR-based, cysteine loop exchange chimaera, termed hIR-Cys loop exchange (CLX), in which all 14 amino acid residues in the exchanged loop differ from wild-type insulin receptor. This loop exchange had a detrimental effect on the efficiency of pro-receptor processing and on the binding of the mouse monoclonal antibody 83-7. However, this antibody, which binds hIR but not hIGF-1R, was still capable of immunoprecipitating the mature chimaeric receptor, indicating that the conformational epitope recognised by this antibody is not primarily determined by the loop region exchanged. The loop exchange did not significantly affect the ability of insulin to displace bound radiolabelled insulin, but increased the capacity of IGF-1 to competitively displace labelled insulin by at least 10 fold.
胰岛素受体(IR)和胰岛素样生长因子-I受体(IGF-1R)对胰岛素和胰岛素样生长因子表现出不同的结合特性。已知IGF-1结合的特异性决定簇位于人IGF-1R第223至274位残基之间的富含半胱氨酸(Cys-rich)区域,该区域包含一个伸入假定配体结合位点的环。在本报告中,我们用人IGF-1R的第253至266位残基替换了人IR的第260至277位残基,以产生一种基于IR的、半胱氨酸环交换嵌合体,称为hIR-半胱氨酸环交换(CLX),其中交换环中的所有14个氨基酸残基均与野生型胰岛素受体不同。这种环交换对前体受体加工效率和小鼠单克隆抗体83-7的结合产生了不利影响。然而,这种结合hIR而不结合hIGF-1R的抗体仍能够免疫沉淀成熟的嵌合受体,这表明该抗体识别的构象表位并非主要由交换的环区域决定。环交换对胰岛素取代结合的放射性标记胰岛素的能力没有显著影响,但使IGF-1竞争性取代标记胰岛素的能力至少提高了10倍。